Objective: Chronic pressure overload in spontaneously hypertensive rats (SHR) is accompanied by heart hypertrophy and signs of heart failure. Since there is growing evidence for a possible pathophysiological role of altered protein phosphorylation in heart hypertrophy and failure, we studied here cardiac regulatory phosphoproteins and the kinases and phosphatases which regulate their phosphorylation state. Methods: The experiments were performed in ventricles of SHR (12-13 weeks old) and age-matched normotensive Wistar-Kyoto rats (WKY). Results: Basal as well as isoproterenol (Iso)-stimulated force of contraction (FOC) was markedly decreased in isolated electrically driven papillary muscles of SHR. Iso (3 mmol / l, 10 min) increased FOC by 0.9160.20 mN in resulting increase of PLB-PT-17 enhanced SR-Ca -uptake in SHR and might contribute to the pathophysiological changes in cardiac hypertrophy of SHR.
Introduction
expression of regulatory proteins in SHR rats were found [6] , the subcellular basis for the loss of b-adrenergic Spontaneously hypertensive rats (SHR) are a well responsiveness remains elusive. established model for hypertension related heart hyperPhosphorylation of cardiac regulatory proteins plays an trophy and heart failure [1] . SHR manifest a progression important role in the regulation of cardiac contractility and from a stable form of hypertrophy with normal cardiac in mediating contractile effects of b-adrenergic catecholfunction to chronic heart failure with impaired heart amines. In the intact isolated heart, b-adrenergic stimulafunction which corresponds well to the clinical course of tion leads to phosphorylation of phospholamban (PLB) on patients with hypertension [2] .
serine-16 by protein kinase A and on threonine-17 by 21 The SHR heart is characterized, similar to other models Ca / calmodulin dependent protein kinase II [7] . PLB is of heart hypertrophy and the failing human heart [3] , by a an intrinsic protein of the sarcoplasmic reticulum (SR) and 21 decreased inotropic response to b-adrenergic stimulation inhibits the function of SR-Ca -ATPase. Stimulation of [4, 5] . Although multiple alterations in the function and b-adrenoceptors increases the phosphorylation state of 21 PLB and thereby enhances Ca -ATPase activity and 21 augments the rate of SR-Ca -uptake. Moreover, SR can *Corresponding author. Tel.: 149-251-835-5517; fax: 149-251-835-5501.É -mail address: boknik@uni-muenster.de (P. Boknık). Time for primary review 26 days. 21 release more Ca for the subsequent contraction. These 2.2. Contraction experiments steps contribute to the inotropic and relaxant effects of b-adrenergic stimulation in the heart [8] . In addition,
The experiments were performed on electrically driven stimulation of b-adrenoceptors increases the phosphorylapapillary muscles from the left ventricles [13, 18] . The tion state of the inhibitory subunit of troponin (TnI), cross-sectional area of papillary muscles amounted to 2 2 localized in thin filaments of cardiac contractile apparatus. 0.6760.10 mm (n510) in WKY and to 0.7860.12 mm Both PLB-and TnI-phosphorylation can hasten cardiac (n59) in SHR, respectively. Force of contraction was relaxation [9] . measured with an inductive force transducer and parameThe two phosphorylation sites of PLB are substrates for ters of contractility were calculated using BEMON-Soft-ẗ ype 1 and 2A protein phosphatases (PP) in vitro. PPs of ware (Ingenieurburo Jackel, Hanau, Germany). type 1 and type 2A could dephosphorylate phospholamban 21 in membranes from rabbit heart phosphorylated in vitro on 2.3. Ca -uptake measurement serine or threonine [10] . Similarly, type 1 and type 2A PP, 21 separated from human ventricle, dephosphorylate recombi-
The rate of SR-Ca -uptake was measured as described nant PLB [11] . [18, 19] . There are several lines of evidence that PLB dephosphorylation contributes to impaired inotropic effects of 2.4. Total RNA preparation b-adrenergic stimulation and cardiac hypertrophy. The 21 deletion of phosphorylation sites for PKA and Ca / CamIn order to extract total RNA, a modification of the PK II greatly diminished inotropic effect of b-adrenergic method described by Chomczynski and Sacchi [20] was stimulation and led to cardiac hypertrophy [12] . Isoemployed. Frozen tissue was homogenized in TriStarproterenol-induced heart hypertrophy was accompanied by ReagentE (AGS, Heidelberg, Germany) and total RNA an increase of PP-activity and dephosphorylation of PLB at was extracted according to the manufacturer's instructions. both phosphorylation sites [13] .
There is also accumulating evidence for a possible 2.5. mRNA quantification pathophysiological role of increased PP-activity in human heart failure. We have shown that PP-activity is enhanced
The cDNA-probes for rat SERCA2a, rat PLB and rat in failing human hearts [14] . This was accompanied by Gsa-subunit were obtained as described by Linck [18] . reduced phosphorylation of cardiac regulatory proteins
The cDNA-probes for CSQ, TnI and catalytic subunits of [15] [16] [17] . The reduced phosphorylation of PLB at serine-16 21 21 PP1 and 2A were constructed by reverse transcriptioncorrelated with the reduced Ca -sensitivity of SR-Capolymerase chain reaction [21] . The blots were hybridized ATPase [17] . 32 subsequently with P-labeled probes against PP1a, PP1b, These data underline the importance of reversible proPP1g, PP2Aa and PP2Ab, CSQ, TnI, SERCA2a, PLB and tein phosphorylation for the regulation of cardiac contracGsa-subunit. For further hybridization, the membranes tility and, in addition, imply its pathophysiological role in were stripped by boiling in 0.1% SDS. Bound radioactivity heart hypertrophy and failure. We hypothesized that alterawas visualized and quantified in a PhosphorImagerE tions of protein phosphorylation may also play a role in (Molecular Dynamics, Krefeld, Germany). early stages of hypertensive hypertrophy. Therefore, we 21 comparatively studied (i) the expression of Ca -regulatory proteins, (ii) the phosphorylation state of phospholam-2.6. Protein quantification ban and the inhibitory subunit of troponin, and (iii) the expression and activity of protein kinases and phosphatases SDS-tissue extracts were prepared as described [19] and in SHR and age-matched Wistar-Kyoto rats.
30 or 100 mg (for quantification of PPs and PLB-phosphorylation) of sample protein were loaded per lane. Western blots for PLB, SERCA and CSQ were performed as described [19] . antibodies was tested in membrane vesicles from rat 1996). Male SHR of 12-13 weeks of age and age-matched ventricles as described [23] . The signals obtained from the normotensive Wistar-Kyoto (WKY) rats were purchased phosphorylation site specific PLB-antibodies were normalfrom Harlan-Winkelmann (Borchen, Germany).
ized to the corresponding values from the A1 PLB-anti- 32 body, which recognizes PLB independently of its phosscribed previously [11, 13] with P-phosphorylase a as phorylation state.
substrate. The phosphorylation state of TnI was measured using the monoclonal antibody 1E11.3 which recognizes TnI 2.8. Protein kinase assays phosphorylated at cardiac specific N-terminal sequence [24, 25] . The signal was normalized using the phosphoryla- 21 Assays on protein kinase A and Ca / calmodulin tion-independent antibody 2F6.6. Both primary antibodies 125 protein kinase II were performed as described previously were detected by I-labeled protein A.
[13].
Protein phosphatase assay 2.9. Data analysis
Protein phosphatase activity was determined as deData shown are means6S.E.M. In Fig. 1 the significant difference from control within SHR and WKY groups was calculated using Student's t-test for paired observations. All statistical comparisons between SHR and WKY were performed using unpaired t-test. A P-value ,0.05 was considered significant.
Results
Fig. 1 summarizes the data from contraction experiments in isolated electrically driven papillary muscles. The basal force of contraction was markedly decreased in SHR and amounted to 2.3660.35 mN (n59) in SHR and to 4.7260.36 mN in WKY (n510). The positive inotropic effect of the b-adrenoceptor agonist isoproterenol was noticeably attenuated in SHR (Fig. 1A) . In addition, basal as well as isoproterenol-stimulated rate of diastolic relaxation was also diminished (Fig. 1B) . However, the EC -50 values for the inotropic as well as relaxant effect of isoproterenol did not differ between SHR and WKY. The diastolic dysfunction might be partly due to a prolonged duration of isometric relaxation (Fig. 1C) . The time to peak tension was comparable and amounted under basal conditions to 57.161.0 ms in WKY (n510) and to 58.361.8 ms in SHR (n59), respectively. 21 21
Next, we determined Ca -dependence of Ca -uptake in the absence and in the presence of the PLB monoclonal antibody 2D12. This PLB antibody reverses the inhibition 21 of SERCA by PLB at low ionized Ca -concentration, giving similar effects as PLB-phosphorylation [19] . Sur-between SHR and WKY as demonstrated in Figs. 4 and 5 and summarized in Table 1 .
Cardiac contractility is tightly controlled by the phosphorylation state of cardiac regulatory proteins. Using phosphorylation specific antibodies [22, 24, 25] we could address the question of altered protein phosphorylation in SHR. Experiments with the PLB-PS-16 antibody revealed no difference between SHR and WKY (Figs. 5 and 6). In contrast, phosphorylation of PLB at threonine-17 was increased in SHR ventricles as demonstrated on representative Western blot using the PLB-PT-17 antibody (Fig. 5) . Moreover, by means of the monoclonal antibody 1E11.3 [24, 25] we were able also to measure the phosphorylation state of TnI. Similar to the phosphorylation of PLB at 21 threonine-17, phosphorylation of TnI was higher in ventri- Since phosphorylation of at least two substrates was 21 21 nmol / l of ionized Ca (A), and fold-stimulation of Ca -uptake by the altered in SHR, we investigated the expression and activity 21 PLB monoclonal antibody 2D12 determined at different ionized labeled PCR-products for mRNA-quantification. As exNext, we addressed whether these differences in contracemplified in Fig. 7 , the mRNA-expression of catalytic 21 tility and Ca -uptake were correlated with altered expressubunits of PP1a, PP1b, PP1g as well as of PP2Aa did sion of cardiac regulatory proteins. PLB and SERCA are not differ between SHR and WKY. In contrast, we could 21 major determinants of SR-Ca -uptake [8] . Calsequestrin not quantify the mRNA-expression of PP2Ab as the (CSQ), a protein located within the SR-lumen, is also abundance of mRNA-transcripts was below detection limit. 21 tightly linked to the regulation of Ca -homeostasis. CSQAccordingly, using antibodies raised against the catalytic overexpression is accompanied by heart hypertrophy and subunits of PP1a and PP2Aa / b we did not find any prolonged relaxation [26] . In addition, we also studied difference in the protein expression between SHR and expression of the inhibitory subunit of troponin (TnI), WKY (Fig. 8) . The data on the expression of catalytic localized in the thin filaments of cardiac contractile subunits of PPs are summarized in Table 2 . In addition, we 32 apparatus. However, as depicted in representative Northern also measured the type 1 and 2A PP-activity using Pblots (Fig. 3) , there was no difference in the mRNAlabeled phosphorylase a. and WKY. In agreement with Marcil et al. [28] , the II (Ca / CaM-PK). Whereas PKA activity under basal mRNA-expression of Gsa-subunit was similar in SHR and conditions (absence of exogenous cAMP) did not differ WKY (Fig. 3) . Therefore, the data for mRNA-expression between SHR and WKY, we found a decrease of PKA were normalized to the corresponding Gsa-value and are activity under conditions of maximal stimulation (2 mmol / 21 given in Table 1 . l cAMP) in SHR-ventricles. As seen in Fig. 9B , CaSince the mRNA-levels do not necessarily reflect the independent (presence of 5 mmol / l EGTA) protein kinase expression of respective genes at protein level [27] 21 21 difference in Ca -transport rates at high ionized CamRNA-and protein-expression was measured as described in Methods.
concentrations. Apparently, this difference was not due to
The data for mRNA-expression were normalized to the corresponding alterations of protein expression since the levels of PLB, Gsa-value. CSQ, calsequestrin; PLB, phospholamban; SERCA, sarco- (CSQ) were similar in SHR and WKY. Hence, we studied the phosphorylation state of PLB, as this is an important 21 21 21 kinase II (Ca / CaM-PK) in ventricles of spontaneously mechanism regulating SR-Ca -uptake. PKA and Ca / hypertensive rats (SHR). This correlated with an enhanced Cam-PK phosphorylate PLB at two different sites: serinephosphorylation of phospholamban at threonine-17 (PLB-16 and threonine-17 [7] . These phosphorylations relieve 21 21 PT17) and an increased rate of Ca -uptake by sarcoplasinhibition of SERCA by PLB, stimulate SR-Ca -uptake mic reticulum.
and shorten cardiac relaxation [8] . Whereas comparable SHR are a well established model of genetic hypertenlevels of PKA-mediated PLB-phosphorylation were found, sion which also enables investigation of subcellular mechathe phosphorylation of PLB at threonine-17 was enhanced nisms responsible for the development of heart hyperin SHR-ventricles. This can explain higher rates of SR- 21 21 trophy. The aim of the present study was to characterize Ca -uptake at low ionized Ca -concentration, which we biochemical alterations in an early stage of hypertensive observed in vitro. hypertrophy. We focused on the age of 12-13 weeks,
The above-mentioned findings are, however, somewhat because this time-point is characterized by stable compensurprising with respect to the observed decrease of contracsated heart hypertrophy [1, 2] . In an integrative approach, tile parameters and the blunted response to isoproterenol in cardiac contractility, expression of cardiac regulatory SHR [4, 5] . One would rather expect an increase of basal proteins and function of cardiac sarcoplasmic reticulum force of contraction and shortening of relaxation due to 21 (SR) were compared between SHR and age-matched enhanced SR-Ca -transport. The reason for this disWistar-Kyoto rats (WKY). Furthermore, we measured crepancy is not clear. In contrast, there is considerable protein phosphorylation and the activity of phosphorylation evidence that PLB dephosphorylation attenuates contractile state regulating enzymes.
effects of b-adrenergic stimulation and may play an proterenol in SHR. On the other hand, the decrease of PKA-activity might be relevant also for cardiac growth as there is evidence for inhibition of mitogen-activated protein kinase-pathway by PKA [36] . Based on data from various animal models [13] and on the findings from human failing hearts [14] , we initially hypothesized also a possible pathophysiological role of protein phosphatases (PP) in SHR. In contrast however, PPs are apparently not a subject of regulation in the early stage of hypertensive hypertrophy. Our experiments characterizing PPs at various levels provide no indication for any alteration of type 1 and 2A PPs in SHR. On the other hand, this may explain the increase of PLB-PT-17 phosphorylation in SHR in contrast to human heart failure. The increase of PP-activity in human failing hearts [14] Another finding, which has to be discussed, is the antibodies 2F6.6 (TnI) and A-1 (PLB). *P,0.05 versus WKY.
increased phosphorylation of TnI despite decreased PKAactivity. The phosphorylation specific antibody 1E11.3, which we used, recognizes the phosphorylated N-terminus important role in the development heart hypertrophy of TnI-molecule [24, 25] . This cardiac specific sequence [12, 13] . However, heart hypertrophy in these models is not contains two adjacent serine residues (23 and 24) that can induced by pressure overload. Thus, one might speculate be phosphorylated by either PKA or under some conditions that a different etiology may account for this discrepancy.
also by protein kinase C (PKC) [38] . We cannot differenNext, we focused on the mechanism of increased PLBtiate, whether the increase of TnI-phosphorylation is due to phosphorylation. The present data indicate that the en-PKA or PKC. Nevertheless, the observed increase in SHR hanced PLB-phosphorylation at threonine-17 is due to concerns the N-terminus where, independently of the 21 increased activity of Ca / calmodulin dependent protein involved kinase (PKA or PKC), the impact of phosphoryl- 21 21 kinase in SHR-ventricles. We have reported an increase of ation is the same: a decrease of Ca -sensitivity of Ca - 21 21 Ca / CaM-PK-activity also in the hearts of patients stimulated Mg -ATPase without affecting its maximal suffering from dilated cardiomyopathy [30] . Fittingly, activity [38, 39] . However, the N-terminus seems not to be Hoch et al. [31] have found increased expression of d3-a primary target for PKC as it is only a weak substrate for 21 PKC in vitro [39] . Thus, we suggest that the increase of isoform of Ca / CaM-PK in failing human hearts. Thus, 21 TnI-phosphorylation in SHR might be due to PKA. The Ca / CaM-PK seems to play an important role in heart discrepancy between the increased TnI-phosphorylation hypertrophy and failure.
and decreased PKA-activity may suggest a local regulation There is accumulating evidence that calmodulin alone or 21 of PKA-activity. One can speculate that the expression of its downstream targets Ca / Cam-PK and calcineurin may PKA regulatory subunits and herewith the anchoring of be crucial regulators of heart hypertrophy. Transgenic catalytic subunits might be altered in SHR [40] . On the overexpression of calmodulin displays heart hypertrophy 21 other hand, the existence of multiple subcellular pools of [32] . Passier et al. [33] have shown that activated Ca / cAMP could also explain this discrepancy. The increase of CaM-PKs I and IV induce hypertrophic responses in PKA-mediated protein phosphorylation seems to be concultured cardiomyocytes. Furthermore, it is also conceiv-21 fined to the cardiac contractile apparatus as the PKAable, that persistent increase of Ca -uptake due to en-21 dependent phosphorylation of PLB is comparable in SHR hanced Ca / CaM-PK-mediated PLB-phosphorylation 21 and WKY. McConnell et al. [41] have reported that leads to SR-Ca -overload favoring the development of isoproterenol led to a higher PKA-dependent phosphorylaheart hypertrophy. Interestingly, cardiac specific overex- 21 tion of TnI in SHR. This was associated with a rightward pression of CSQ, which increases SR-Ca -stores, leads to 21 21 shift in the Ca -dependence of the actomyosin Mgheart hypertrophy and failure in transgenic animals [26] .
ATPase-activity as compared to WKY. Thus, it is conceivThe observed decrease of PKA-activity is in agreement able that the higher basal TnI-phosphorylation may conwith previous findings of Bhalla et al. [34] and most tribute to lower basal force development observed in our probably reflects the reduction of type I PKA reported by study. The enhanced N-terminal phosphorylation of TnI Prashad [35] . We suggest that the PKA decrease may in along with the increased PLB-PT-17 phosphorylation part also explain the weak contractile response to iso- Fig. 7 . mRNA-expression of catalytic subunits of protein phosphatase 1a (PP1a ), PP1b, PP1g and PP2Aa in ventricles of spontaneously hypertensive CAT (SHR) and Wistar-Kyoto rats (WKY). A 20-mg amount of total mRNA was electrophoresed, transferred on nylon membrane and hybridized with 32 P-labeled cDNA-probes. Radioactive bands were visualized using PhosphorImagerE. Protein binding antibodies were visualized using I-labeled goat anti-rabbit IgG. Radioactive bands were visualized using PhosphorImagerE. On the left, molecular weight markers in kDa are indicated. might also counteract the impaired relaxation in SHR.
creases force of contraction. Interestingly, there is evidence Apparently, these compensatory mechanisms are not suffifor upregulation of the PKC-cascade in SHR [42] . Thus, an cient to normalize the duration of cardiac relaxation.
increased PKC-mediated phosphorylation seems to be Besides Ser-23 and 24 the cardiac TnI contains multiple important not only for the development of heart hyperphosphorylation sites for PKC, namely Ser-43, Ser-45, trophy but might contribute also to the depressed contracSer-78 and Thr-144 [39] . Their phosphorylation inhibits tility in SHR. 21 21 the Ca -stimulated actomyosin Mg -ATPase and deIn summary, we have shown that the activity of the 21 Ca / calmodulin dependent protein kinase is increased in SHR-ventricles. This leads to enhanced phosphorylation of phospholamban at threonine-17 and stimulation of SR- Table 2 21
Ca -uptake. These alterations might contribute to the Expression of catalytic subunits of protein phosphatases (PP) at mRNApathophysiological changes in heart hypertrophy. In addiand protein-levels in ventricles of spontaneously hypertensive (SHR, n59) and Wistar-Kyoto rats (WKY, n510) tion, a lower basal and isoproterenol-stimulated contractility may be partly due to the increased N-terminal phos- 10 mg / ml calmodulin (Ca / CaM). Ca -independent protein kinase activity was determined in the presence of 5 mmol / l EGTA. *P,0.05 versus WKY.
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